Tag Archives: Backs

EMA Panel Backs Daridorexant (Quviviq) for Insomnia

The Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) has recommended approval of daridorexant (Quviviq, Idorsia Pharmaceuticals) for the treatment of insomnia. Daridorexant is a dual orexin receptor antagonist that has been shown to increase sleep induction, improve sleep maintenance, and improve daytime functioning. The drug is indicated for the […]